SG11201602661PA - Novel peptide compositions - Google Patents

Novel peptide compositions

Info

Publication number
SG11201602661PA
SG11201602661PA SG11201602661PA SG11201602661PA SG11201602661PA SG 11201602661P A SG11201602661P A SG 11201602661PA SG 11201602661P A SG11201602661P A SG 11201602661PA SG 11201602661P A SG11201602661P A SG 11201602661PA SG 11201602661P A SG11201602661P A SG 11201602661PA
Authority
SG
Singapore
Prior art keywords
novel peptide
peptide compositions
compositions
novel
peptide
Prior art date
Application number
SG11201602661PA
Other languages
English (en)
Inventor
Richard Franklin
Original Assignee
Tarix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tarix Pharmaceuticals Ltd filed Critical Tarix Pharmaceuticals Ltd
Publication of SG11201602661PA publication Critical patent/SG11201602661PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG11201602661PA 2013-10-11 2014-10-01 Novel peptide compositions SG11201602661PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361890056P 2013-10-11 2013-10-11
US201461940095P 2014-02-14 2014-02-14
PCT/US2014/058646 WO2015054006A2 (en) 2013-10-11 2014-10-01 Novel peptide compositions

Publications (1)

Publication Number Publication Date
SG11201602661PA true SG11201602661PA (en) 2016-05-30

Family

ID=52813728

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201602661PA SG11201602661PA (en) 2013-10-11 2014-10-01 Novel peptide compositions

Country Status (13)

Country Link
EP (1) EP3054967A4 (ja)
JP (1) JP2017501967A (ja)
KR (1) KR20160065969A (ja)
CN (1) CN105828831A (ja)
AU (1) AU2014332346B2 (ja)
BR (1) BR112016007816A2 (ja)
CA (1) CA2926641A1 (ja)
CL (1) CL2016000836A1 (ja)
IL (1) IL244956B (ja)
MX (1) MX2016004660A (ja)
RU (1) RU2016112931A (ja)
SG (1) SG11201602661PA (ja)
WO (1) WO2015054006A2 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017150327A1 (ja) * 2016-03-03 2017-09-08 不二製油グループ本社株式会社 神経栄養因子の脳内分泌促進するための食品添加用組成物
EP3583944A4 (en) * 2017-02-16 2021-03-03 Caregen Co., Ltd. CONJUGATE OF SALICYLIC ACID AND PEPTIDE

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244946A (en) 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
US4305872A (en) 1979-10-19 1981-12-15 Kenneth Wingrove Polypeptide derivatives
US4316891A (en) 1980-06-14 1982-02-23 The Salk Institute For Biological Studies Extended N-terminal somatostatin
CA2259966A1 (en) 1996-07-12 1998-01-22 Mcgill University Compounds and methods for modulating cell adhesion
US20020168761A1 (en) 2000-01-24 2002-11-14 Gour Barbara J. Peptidomimetic modulators of cell adhesion
US7563862B2 (en) * 2001-08-24 2009-07-21 Neuren Pharmaceuticals Limited Neural regeneration peptides and methods for their use in treatment of brain damage
JP4399260B2 (ja) * 2001-08-24 2010-01-13 ニューレン ファーマシューティカルズ リミテッド 神経再生ペプチドおよび脳損傷治療におけるその使用方法
AU2003293807A1 (en) * 2002-12-24 2004-07-22 Algonomics N.V. Mhc class i restricted t-cell stimulating peptides from hepatitis b virus
JP5026083B2 (ja) * 2003-10-31 2012-09-12 クロンズ ホールディングズ カンパニー リミテッド 神経再生ペプチド及び脳損傷治療におけるそれらの使用方法
WO2007011595A2 (en) * 2005-07-15 2007-01-25 Neuren Pharmaceuticals Limited Neural regeneration peptides and antioxidants protect neurons from degeneration
US9296805B2 (en) * 2009-06-18 2016-03-29 Dana-Farber Cancer Institute, Inc. Stabilized insulinotropic peptides and methods of use
WO2013119870A1 (en) * 2012-02-10 2013-08-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of peripheral vascular disease

Also Published As

Publication number Publication date
CN105828831A (zh) 2016-08-03
KR20160065969A (ko) 2016-06-09
CA2926641A1 (en) 2015-04-16
CL2016000836A1 (es) 2016-09-16
EP3054967A2 (en) 2016-08-17
IL244956B (en) 2019-10-31
JP2017501967A (ja) 2017-01-19
IL244956A0 (en) 2016-05-31
MX2016004660A (es) 2016-11-14
RU2016112931A3 (ja) 2018-06-20
EP3054967A4 (en) 2017-04-19
WO2015054006A2 (en) 2015-04-16
AU2014332346B2 (en) 2019-01-24
WO2015054006A3 (en) 2015-06-04
RU2016112931A (ru) 2017-11-16
AU2014332346A1 (en) 2016-05-05
BR112016007816A2 (pt) 2017-12-05

Similar Documents

Publication Publication Date Title
HK1216757A1 (zh) 肽化合物
GB201304662D0 (en) Compositions
SG11201602596UA (en) Stabilized efinaconazole compositions
ZA201505966B (en) Peptides and compositions
HK1220697A1 (zh) 肽組合物
GB201303771D0 (en) Nanoparticles peptide compositions
GB201608461D0 (en) Compositions
GB201317105D0 (en) Novel Composition
HUE050164T2 (hu) Új négy-CTL epitóp-kapcsolt peptid
HK1216715A1 (zh) 基於血紅蛋白衍生肽的新型藥物組合物
HK1211596A1 (en) Peptide
GB201316463D0 (en) Novel compositions
HK1211595A1 (en) Peptide
ZA201505650B (en) New compositions
HK1198769A1 (en) Novel peptide
GB201319923D0 (en) Novel composition
GB201310513D0 (en) Novel composition
IL244956B (en) New peptide compositions
GB201320962D0 (en) Compositions
GB201303787D0 (en) Nanoparticle peptide compositions
GB201320959D0 (en) Compositions
GB201316464D0 (en) Novel compositions
GB201315598D0 (en) Novel compositions
GB201312224D0 (en) Compositions
GB201322510D0 (en) Novel composition